Perfusion MR imaging in brain tumors;IRM de perfusion des tumeurs cérébrales

Journal de Radiologie

Volumn 87, Issue 6 C2, 2006, Pages 807-821

  Le Bas, J F ^a   Grand, S ^a   Krainik, A ^a   Lefournier, V ^a   Tropres, I ^a   Remy C ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Brain neoplasms, MR; Magnetic Resonance (MR), contrast enhancement; Magnetic Resonance (MR), Perfusion study

Indexed keywords

GADOLINIUM;

ARTICLE; BRAIN TUMOR; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; PERFUSION WEIGHTED IMAGING; TUMOR DIAGNOSIS;

EID: 33745280098     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(06)74089-6     Document Type: Article

References (22)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Scappaticci FA. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol 2002;20:3906-27.
3. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65.
4. De Marco G, Idy-Peretti I, Tropres I et al. Perfusion cérébrale : IRM dynamique de contraste de susceptibilité magnétique. Partie I : principe et théorie. Med Nucl 2003:27:547-56.
5. Sorensen AG, Reimer P. Cerebral MR perfusion imaging. Principles and current applications. New York: Thieme; 2000.
6. Bruening R, Berchtenbreiter C, Holzknecht N et al. Effects of three different doses of a bolus injection of Gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study. AJNR 2000;21:1603-10.
7. Wetzel SG, Cha S, Johnson G et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intra-observer reproducibility study. Radiology 2002;224:797-803.
8. Hamon M, Coskun O, Courthéoux P, Théron J, Leclerc X. IRM de diffusion du système nerveux central : applications cliniques. J Radiol 2005;86:369-85.
9. Pierot L. RSNA 2004 : neuroradiologie. J Radiol 2005;86:868-73.
10. Aronen HJ, Perkio J. Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 2002;12:501-23.
11. Kremer S, Grand S, Remy C et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002;29:105-13.
12. Lev MH, Ozsunar Y, Henson JW et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR 2004;25:214-21.
13. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994;31:601-10.
14. Knopp EA, Cha S, Johnson G et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-8.
15. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-9.
16. Ball WS Jr, Holland SK. Perfusion imaging in pediatric patient. Magn Reson Imaging Clin N Am 2001;9:207-30.
17. Law M, Yang S, Babb JS et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR 2004;25:746-55.
18. Schmainda KM, Rand SD, Joseph AM et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR 2004;25:1524-32.
19. Daumas-Duport C, Tucker ML, Kolles H et al. Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol 1997;34:61-78.
20. Corot C, Petry KG, Trivedi R et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Rad 2004;39:619-25.
21. Tropres I, Grimault S, Vaeth A et al. Vessel size imaging. Magn Reson Med 2001;45:397-408.
22. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR 2000;21:462-70.